EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Epilepsy & Behavior

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yebeh.2017.03.033PMID 28645087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

  2016influential reference
• Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment.

  2015cited by this paper
• Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.

  2015cited by this paper
• Candidate drug targets for prevention or modification of epilepsy.

  2015cited by this paper
• Complex alterations in microglial M1/M2 markers during the development of epilepsy in two mouse models

  2015cited by this paper
• Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.

  2015cited by this paper
• Prostanoid receptor EP2 as a therapeutic target.

  2014cited by this paper
• Epilepsy and Inflammation in the Brain: Overview and Pathophysiology

  2014cited by this paper
• Commentary on Kaushik et al.: Prostaglandin D2 is crucial for seizure suppression and postictal sleep. Novel evidence supporting a role for prostanoid receptors in seizure control.

  2014cited by this paper
• Prostaglandin D(2) is crucial for seizure suppression and postictal sleep.

  2014influential reference
• Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.

  2013cited by this paper
• EP2 Receptor Signaling Pathways Regulate Classical Activation of Microglia*

  2013cited by this paper
• Suppression of Inflammation with Conditional Deletion of the Prostaglandin E2 EP2 Receptor in Macrophages and Brain Microglia

  2013cited by this paper
• Role of Prostaglandin Receptor EP2 in the Regulations of Cancer Cell Proliferation, Invasion, and Inflammation

  2013cited by this paper
• A role for inflammation in status epilepticus is revealed by a review of current therapeutic approaches

  2013cited by this paper
• Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation

  2013influential reference
• Prostaglandin E2 potentiates methylmalonate‐induced seizures

  2012cited by this paper
• Inflammation in epilepsy: Clinical observations

  2011cited by this paper
• Ablation of Cyclooxygenase-2 in Forebrain Neurons is Neuroprotective and Dampens Brain Inflammation after Status Epilepticus

  2011cited by this paper
• Emerging roles of PGE2 receptors in models of neurological disease.

  2010cited by this paper
• The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke

  2010cited by this paper
• A revised Racine's scale for PTZ-induced seizures in rats.

  2009cited by this paper
• Functional definition of seizure provides new insight into post-traumatic epileptogenesis

  2009cited by this paper
• Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2.

  2009cited by this paper
• Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin.

  2008cited by this paper
• The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis

  2008cited by this paper
• Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors.

  2008cited by this paper
• Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.

  2008cited by this paper
• yclooxygenase-2 / PGE 2 pathway facilitates entylenetetrazol-induced seizures

  2008cited by this paper
• Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein

  2007cited by this paper
• New Roles for Interleukin-1 Beta in the Mechanisms of Epilepsy

  2007cited by this paper
• Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage.

  2006cited by this paper
• Deletion of the Prostaglandin E2 EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease

  2005cited by this paper
• Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia

  2005cited by this paper
• Neuroprotective Function of the PGE2 EP2 Receptor in Cerebral Ischemia

  2004cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Regulation of glial glutamate transporter expression by growth factors.

  2003cited by this paper
• The Mouse Brain in Stereotaxic Coordinates

  2001cited by this paper
• Genetic and pharmacological analysis of prostanoid receptor function.

  2001cited by this paper
• Alteration of second messengers during acute cerebral ischemia - adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein.

  2001cited by this paper
• Aqueous flare elevation induced by transcorneal application of highly selective agonists for prostaglandin E2 receptor subtypes in pigmented rabbits: effect of tetramethylpyrazine.

  2001cited by this paper
• The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.

  2000cited by this paper
• Prostanoid receptors: structures, properties, and functions.

  1999cited by this paper
• Distribution, regulation and colocalization of the genes encoding the EP2‐ and EP4‐PGE2 receptors in the rat brain and neuronal responses to systemic inflammation

  1999cited by this paper
• Cilostazol, a cyclic AMP phosphodiesterase inhibitor, stimulates nitric oxide production and sodium potassium adenosine triphosphatase activity in SH-SY5Y human neuroblastoma cells.

  1999cited by this paper
• Calcium-Induced Calcium Release Contributes to Action Potential-Evoked Calcium Transients in Hippocampal CA1 Pyramidal Neurons

  1999cited by this paper
• Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells

  1998cited by this paper
• Dentate Granule Cell Neurogenesis Is Increased by Seizures and Contributes to Aberrant Network Reorganization in the Adult Rat Hippocampus

  1997cited by this paper
• Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells

  1997cited by this paper
• Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.

  1994cited by this paper
• Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis

  1993cited by this paper
• Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis.

  1984cited by this paper

• The potential role of COX-2/PGs signaling pathway in epileptogenesis and associated neuroinflammation: collusions or serendipity

  2026cites this paper
• Cyclooxygenase-1 deletion in 5 × FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment

  2025influential citation
• Modulating inflammatory prostaglandin E2 signaling to mitigate neurobehavioral comorbidities associated with seizure disorders

  2025cites this paper
• Effect of alpelisib, a selective phosphatidylinositol-3-kinase inhibitor, on seizure development in a rat pentylenetetrazole model

  2024cites this paper
• Effect of amitriptyline on learning and memory consolidation in the male Wistar rats with an experimental model of pentylenetetrazole-induced seizure

  2023cites this paper
• Idelalisib, a Selective Phosphatidylinositol-3-Kinase Inhibitor, Suppresses Pentylenetetrazole-Induced Convulsions in Wistar Rats

  2023cites this paper
• Multiple Disruptions of Glial-Neuronal Networks in Epileptogenesis That Follows Prolonged Febrile Seizures

  2021cites this paper
• Anticonvulsant and neuroprotective effects of carbamazepine-levetiracetam adjunctive treatment in convulsive status epilepticus rat model: inhibition of cholinergic transmission.

  2021cites this paper
• Mechanisms and potential therapeutic targets for spontaneous intracerebral hemorrhage

  2020cites this paper
• Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management

  2019cites this paper
• WITHDRAWN: Mechanisms and potential therapeutic targets for intracerebral hemorrhage

  2019cites this paper
• Time dependent dual effect of anti-inflammatory treatments on sarin-induced brain inflammation: Suggested role of prostaglandins.

  2019cites this paper
• Novel drugs and early polypharmacotherapy in status epilepticus.

  2019cites this paper
• A gain-of-function study of amelioration of pentylenetetrazole-induced seizures by endogenous prostaglandin D2.

  2018cites this paper
• Inflammation: A Network in the Pathogenesis of Status Epilepticus

  2018cites this paper
• Systemic delivery of selective EP1 and EP3 receptor antagonists attenuates pentylenetetrazole-induced seizures in mice.

  2018cites this paper